Creon - 17856-1206-1 - (Pancrelipase)

Alphabetical Index


Drug Information of Creon

Product NDC: 17856-1206
Proprietary Name: Creon
Non Proprietary Name: Pancrelipase
Active Ingredient(s): 30000; 6000; 19000    [USP'U]/1; [USP'U]/1; [USP'U]/1 & nbsp;   Pancrelipase
Administration Route(s): ORAL
Dosage Form(s): CAPSULE, DELAYED RELEASE PELLETS
Coding System: National Drug Codes(NDC)

Labeler Information of Creon

Product NDC: 17856-1206
Labeler Name: Atlantic Biologicals Corps
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA020725
Marketing Category: NDA
Start Marketing Date: 20100813

Package Information of Creon

Package NDC: 17856-1206-1
Package Description: 1 CAPSULE, DELAYED RELEASE PELLETS in 1 POUCH (17856-1206-1)

NDC Information of Creon

NDC Code 17856-1206-1
Proprietary Name Creon
Package Description 1 CAPSULE, DELAYED RELEASE PELLETS in 1 POUCH (17856-1206-1)
Product NDC 17856-1206
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Pancrelipase
Dosage Form Name CAPSULE, DELAYED RELEASE PELLETS
Route Name ORAL
Start Marketing Date 20100813
Marketing Category Name NDA
Labeler Name Atlantic Biologicals Corps
Substance Name PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASE
Strength Number 30000; 6000; 19000
Strength Unit [USP'U]/1; [USP'U]/1; [USP'U]/1
Pharmaceutical Classes

Complete Information of Creon


General Information